Arber DA, Orazi A, Hasserjian RP, Brunning RD, Le Beau MM, Porwit A, Tefferi A, Levine R, Bloomfield CD, Cazzola M, Thiele J (2017) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC press, Lyon

Google Scholar 

Glockenberg K, Weinberg EM, Wan DW (2015) A sinister cause of hematemesis. Gastroenterology. https://doi.org/10.1053/j.gastro.2014.09.033

Article  PubMed  Google Scholar 

Valla D, Casadevall N, Huisse MG, Tulliez M, Grange JD, Muller O, Binda T, Varet B, Rueff B, Benhamou JP (1988) Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders. Gastrenterology 94:1063–1069

Article  CAS  Google Scholar 

Smalberg JH, Darwish MS, Braakman E, Valk PJ, Janssen HL, Leebeek FW (2006) Myeloproliferative disease in the pathogenesis and survival of Budd-Chiari syndrome. Haematologica 91:1712–1713

PubMed  Google Scholar 

Kiladjian JJ, Cervantes F, Leebeek FW, Marzac C, Cassinat B, Chevret S, Cazals-Hatem D, Plessier A, Garcia-Pagan JC, Darwish Murad S, Raffa S, Janssen HL, Gardin C, Cereja S, Tonetti C, Giraudier S, Condat B, Casadevall N, Fenaux P, Valla DC (2008) The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases. Blood 111:4922–4929

Article  CAS  PubMed  Google Scholar 

Turon F, Cervantes F, Colomer D, Baiges A, Hernandez-Gea V, Garcia-Pagan JC (2015) Role of calreticulin mutations in aetiological diagnosis of splanchnic vein thrombosis. J Hepatol 62:72–74

Article  CAS  PubMed  Google Scholar 

Smalberg JH, Arends LR, Valla DC, Kiladjian JJ, Janssen HL, Leebeek FW (2012) Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis. Blood 120:4921–4928

Article  CAS  PubMed  Google Scholar 

Degott C, Capron JP, Bettan L, Molas G, Bernuau D, Potet F, Feldmann G, Benhamou JP (1985) Myeloid metaplasia, perisinusoidal fibrosis and nodular regenerative hyperplasia of the liver. Liver 5:276–281

Article  CAS  PubMed  Google Scholar 

Roux D, Merlio JP, Quinton A, Lamouliatte H, Balabaud C, Bioulac-Sage P (1987) Agnogenic myeloid metaplasia, portal hypertension and sinusoidal abnormalities. Gastroenterology 92:1067–1072

Article  CAS  PubMed  Google Scholar 

Wanless IR, Peterson P, Das A, Boitnott JK, Moore GW, Bernier V (1990) Hepatic vascular disease and portal hypertension in polycythaemia vera and agnogenic myeloid metaplasia: a clinicopathological study of 145 patients examined in autopsy. Hepatology 12:1166–1174

Article  CAS  PubMed  Google Scholar 

Mayer J, Schiano TD, Fiel MI, Hoffman R, Mascarenhas JO (2014) An association of myeloproliferative neoplasms and obliterative portal veinopathy. Dig Dis Sci 59:1638–1641

Article  PubMed  Google Scholar 

Valla DC, Cazals-Hatem D (2018) Vascular liver diseases on the clinical side: definitions and diagnosis, new concepts. Virchows Arch 473:3–13

Article  PubMed  Google Scholar 

Marin Oyarzun CP, Heller PG (2019) Platelets as mediators of thromboinflammation in chronic myeloproliferative neoplasms. Front Immunol 10:1373

Article  PubMed  PubMed Central  Google Scholar 

Brunt EM, Gouw ASH, Hubscher SG, Tiniakos DG, Bedossa P, Burt AD, Callea F, Clouston AD, Dienes HP, Goodman ZD, Roberts EA, Roskams T, Terracciano L, Torbenson MS, Wanless I (2014) Pathology of the liver sinusoids. Histopathology 64:907–920

Article  PubMed  Google Scholar 

Liu CL, Prapong W, Natkunam Y, Alizadeh A, Montgomery K, Gilks CB, van de Rijn M (2002) Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. Am J Pathol 161:1557–1565

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eisen MB, Spellman PT, Brown PO, Botstein. (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863–14868

Article  CAS  PubMed  PubMed Central  Google Scholar 

Büttner-Herold M, Sticht C, Wiech T, Porubsky S (2021) Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms. Histopathology 78:738–748

Article  PubMed  Google Scholar 

Lagana SM, Kudose S, Iuga AC, Lee MJ, Fazlollahi L, Remotti HE, El Portillo A, De Michele S, Koehne de Gonzalez A, Saqi A, Khairallah P, Chong AM, Park H, Uhlemann A-C, Lefkowitch J, Verna EC (2020) Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data. Mod Pathol 33:2147–2155

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao CL, Rapkiewicz A, Maghsoodi-Deerwester M, Gupta M, Cao W, Palaia T, Zhou J, Ram B, Vo D, Rafiee B, Hossein-Zadeh Z, Dabiri B, Hanna I (2021) Pathological findings in the post-mortem liver of patients with coronavirus disease 2019 (COVID-19). Hum Pathol 109:59–68

Article  CAS  PubMed  Google Scholar 

Scheuer PJ, The liver and haematological disorders, (1980). In: Scheuer PJ (ed) Liver biopsy interpretation, 3rd edn. Bailliere Tindall, London, pp 221–223

Google Scholar 

Pieri G, Theocharidou E, Burroughs AK (2013) Liver in haematological disorders. Best Pract Res Clin Gastroenterol 27:513–530

Article  CAS  PubMed  Google Scholar 

Tan HK, Leow WQ, Chang PE (2019) Ruxolitinib for the treatment of portal hypertension in a patient with primary myelofibrosis. Gastroenterology. https://doi.org/10.1053/j.gatro.2016.08.059

Article  PubMed  PubMed Central  Google Scholar 

Hobbs CM, Manning H, Bennett C, Vasquez L, Severin S, Brain L, Mazharian A, Guerrero JA, Li J, Soranzo N, Green AR, Watson SP, Ghevaert C (2013) JAK V617F leads to intrinsic changes in platelet formation and reactivity in a knock-in mouse model of essential thrombocythemia. Blood 122:3787–3797

Article  CAS  PubMed  PubMed Central  Google Scholar 

Etheridge SL, Roh ME, Cosgrove ME, Sangkhae V, Fox NE, Chen J, López JA, Kaushansky K, Hitchcock IS (2014) JAK V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms. Proc Natl Acad Sci USA 111:2295–2300

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bekendam RH, Ravid K (2023) Mechanisms of platelet activation in cancer-associated thrombosis: a focus on myeloproliferative neoplasms. Front Cell Dev Biol 11:1207395

Article  PubMed  PubMed Central  Google Scholar 

Tripodi A, Anstee QM, Sogaard KK, Primignani M, Valla D (2011) Hypercoagulability in cirrhosis: causes and consequences. J Thromb Haemost 9:1713–1723

Article  CAS  PubMed  Google Scholar 

Yan M, Geyer H, Mesa R, Attalah E, Callum J, Bartosko J, Yee K, Maganti M, Wong F, Gupta V (2015) Clinical features of patients with Philadelphia-negative myeloproliferative neoplasms complicated by portal hypertension. Clin Lymphoma Myeloma Leuk 15:e1–e5

Article  PubMed  Google Scholar 

Abu-Hilal M, Tawaker J (2009) Portal hypertension secondary to myelofibrosis with myeloid metaplasia: a study of 13 cases. World J Gastroenterology 15:3128–3133

Article  Google Scholar 

Dubois A, Dauzat M, Pignodel C, Pomier-Layrargues G, Marty-Double C, Lopez FM, Janbon C (1993) Portal hypertension in lymphoproliferative and myeloproliferative disorders hemodynamic and histological correlations. Hepatology 17:246–250

Article  CAS  PubMed  Google Scholar 

Chauhan A, Adams DH, Watson SP, Lalor PF (2016) Platelets: no longer bystanders in liver disease. Hepatology 64:1774–1784

Article  PubMed  Google Scholar